Cargando…
Silencing MR-1 Protects against Myocardial Injury Induced by Chronic Intermittent Hypoxia by Targeting Nrf2 through Antioxidant Stress and Anti-Inflammation Pathways
BACKGROUND: Patients with obstructive sleep apnea hypopnea syndrome (OSAHS) often have cardiac insufficiency mainly due to hypoxia/reperfusion injury caused by chronic intermittent hypoxia (CIH). Inflammation and oxidative stress are involved in the cardiovascular events of OSAHS patients. Studies h...
Autores principales: | Wang, Qixue, Wang, Yue, Zhang, Jiner, Pan, Shuo, Liu, Shaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749373/ https://www.ncbi.nlm.nih.gov/pubmed/35028117 http://dx.doi.org/10.1155/2022/3471447 |
Ejemplares similares
-
Retracted: Silencing MR-1 Protects against Myocardial Injury Induced by Chronic Intermittent Hypoxia by Targeting Nrf2 through Antioxidant Stress and Anti-Inflammation Pathways
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Protective Effect of Lactobacillus rhamnosus GG and its Supernatant against Myocardial Dysfunction in Obese Mice Exposed to Intermittent Hypoxia is Associated with the Activation of Nrf2 Pathway
por: Xu, Hui, et al.
Publicado: (2019) -
Intermittent hypoxia simulating obstructive sleep apnea causes pulmonary inflammation and activates the Nrf2/HO-1 pathway
por: Wang, Yeying, et al.
Publicado: (2017) -
Effects of Antioxidant Tempol on Systematic Inflammation and Endothelial Apoptosis in Emphysematous Rats Exposed to Intermittent Hypoxia
por: Zhao, Haiyan, et al.
Publicado: (2018) -
Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice
por: Zhou, Shanshan, et al.
Publicado: (2018)